Search results
Bernie Sanders Wants to Subpoena Novo Nordisk Over Wegovy’s Price. What to Know.
Barrons.com· 3 hours agoSTOCK ALERT Danish drugmaker Novo Nordisk shares were under pressure on Tuesday after Sen. Bernie ...
Senate committee to vote on subpoena for Novo Nordisk executive
The Hill via Yahoo News· 1 day agoSen. Bernie Sanders (I-Vt.), chair of the Senate Health, Education, Labor and Pensions (HELP)...
Benjamin Netanyahu to address Congress on July 24 as Israel-Hamas war hits inflection point
USA Today· 5 days agoIsraeli Prime Minister Benjamin Netanyahu will address a joint meeting of Congress on July 24 in...
Vermont becomes first state to make fossil fuel companies pay for climate change
The Week· 7 days agoVermont has just passed a groundbreaking new law to deal with the effects of climate change — by...
What we keep getting wrong in the Middle East
The Hill· 5 hours agoIt all begins with what our future leaders in business, politics, the media, and academics learn as students on U.S. college campuses. As Eli Lake wrote...
Who is Leonard Peltier? The Native American activist who faces his first parole hearing in 15 years
WJZY via Yahoo News· 2 days agoAdvocates for his parole or release have included Pope Francis, Amnesty International, and the late...
Democrats fractured over views of pro-Palestinian campus protests, poll finds
Politico via Yahoo News· 1 day ago“I worry very much that President Biden is putting himself in a position where he has alienated not...
Pharma CEO facing subpoena over Ozempic cost: 'Highest prices in the world'
KOMO Seattle· 1 day agoA Senate committee will vote next week on issuing a subpoena to Doug Langa, the president of the...
What If the U.S. Cuts Off Aid to Israel?
Reason.com via Yahoo News· 3 days agoBernie Sanders (I–Vt.) said last November, reiterating a critique he and several other candidates made when seeking the 2020 Democratic presidential...
Democrats ramp up patent fight with drug industry in bid to lower prices
Anchorage Daily News· 5 days agoDemocrats have hit on a new tactic in their long battle with drug companies: challenge patents that...